Muscle stem cells produce a protective Fibrillin-1 matrix to prevent precocious activation
Science Advances · 2026
DOI: 10.1126/sciadv.aeb8190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Eleni Chrysostomou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades (INEM), 75015 Paris, France. Hauptthemen laut MEDLINE: Fibrillin-1, Extracellular Matrix, Stem Cells. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: French National Research Agency, Association Française contre les Myopathies, AFM-Telethon.
Abstract (Originalsprache)
Diverse biological mechanisms regulate muscle stem cell quiescence, including inhibition of differentiation, adhesion, and translational control. Here, we identify the matrix glycoprotein Fibrillin-1 (FBN1) as a Notch-regulated, cell-autonomous effector, essential for maintaining quiescence. Known for its causal role in Marfan syndrome (MFS), our work positions FBN1 as a critical niche component that protects muscle stem cells from aberrant growth factor signaling. Targeted deletion of Fbn1 in muscle stem cells leads to dose-dependent quiescence defects, characterized by loss of cellular projections, depletion of the stem cell pool, and progressive decline in muscle function. Consistently, human MFS muscle biopsies show abnormally activated satellite cells, implicating stem cell imbalance in the development of MFS-associated myopathy. Mechanistically, the loss of FBN1 up-regulates transforming growth factor–β (TGFβ) signaling, and pharmacological blockade of TGFβ signaling rescues the cellular and physiological defects of FBN1-deficient muscle. These findings reveal a new quiescence-preserving mechanism through extracellular matrix–mediated shielding from mitogenic signals and position stem cell dysfunction as a driver of MFS myopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades (INEM), 75015 Paris, France.
- Univ Paris Est Créteil, INSERM, IMRB, EnvA, APHP, EFS, F-94010 Créteil, France.
- Faculté de Médecine Paris Descartes, 15 rue de l'École de médecine, 75006 Paris, France.
- Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands.
- Faculty of Medicine and Health Sciences, Department of Anatomy and Cell Biology, McGill University, Montréal, QC, Canada.
- Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, Canada.
ORCID-Profile: Eleni Chrysostomou, Oussama Smail, Artemis Vlachopoulou, Takuto Hayashi, Nicol Voermans, Dieter P Reinhardt, Frederic Relaix, Philippos Mourikis
Förderung
- French National Research Agency
- Association Française contre les Myopathies
- AFM-Telethon
- Genetic Aortic Disorders Association Canada
- LABEX REVIVE
- NWO
Zitieren
APA
Chrysostomou, E., Smail, O., Vlachopoulou, A., Hayashi, T., Tcheng, N., Voermans, N., Reinhardt, D. P., Relaix, F., & Mourikis, P. (2026). Muscle stem cells produce a protective Fibrillin-1 matrix to prevent precocious activation. Science Advances. https://doi.org/10.1126/sciadv.aeb8190
Vancouver
Chrysostomou E, Smail O, Vlachopoulou A, Hayashi T, Tcheng N, Voermans N, et al. Muscle stem cells produce a protective Fibrillin-1 matrix to prevent precocious activation. Science Advances. 2026. doi:10.1126/sciadv.aeb8190
BibTeX
@article{Chrysostomou2026,
author = {Chrysostomou, Eleni and Smail, Oussama and Vlachopoulou, Artemis and Hayashi, Takuto and Tcheng, Nicolas and Voermans, Nicol and Reinhardt, Dieter P and Relaix, Frederic and Mourikis, Philippos},
title = {Muscle stem cells produce a protective Fibrillin-1 matrix to prevent precocious activation},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeb8190}
}
EUVIMED